Correlation Between Processa Pharmaceuticals and Covalon Technologies

Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Covalon Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Covalon Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Processa Pharmaceuticals and Covalon Technologies, you can compare the effects of market volatilities on Processa Pharmaceuticals and Covalon Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Covalon Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Covalon Technologies.

Diversification Opportunities for Processa Pharmaceuticals and Covalon Technologies

0.78

Correlation Coefficient

Processa Pharmaceuticals  Covalon Technologies

Poor diversification

The 3 months correlation between Processa and Covalon is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Covalon Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Covalon Technologies and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Covalon Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Covalon Technologies has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Covalon Technologies go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Covalon Technologies

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to under-perform the Covalon Technologies. In addition to that, Processa Pharmaceuticals is 1.23 times more volatile than Covalon Technologies. It trades about -0.22 of its total potential returns per unit of risk. Covalon Technologies is currently generating about -0.09 per unit of volatility. If you would invest  221.00  in Covalon Technologies on December 2, 2024 and sell it today you would lose (37.00) from holding Covalon Technologies or give up 16.74% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Processa Pharmaceuticals  vs.  Covalon Technologies

Processa Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Covalon Technologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Covalon Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Processa Pharmaceuticals and Covalon Technologies

The main advantage of trading using opposite Processa Pharmaceuticals and Covalon Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Covalon Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Covalon Technologies will offset losses from the drop in Covalon Technologies' long position.

The idea behind Processa Pharmaceuticals and Covalon Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.